MSD ANIMAL HEALTH ACQUIRES SCAN AQUA AS
MSD Animal Health Acquires Scan Aqua AS – MSD Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., USA, has signed a definitive agreement to acquire Scan Aqua AS, the operational affiliate of Scanvacc AS, a company with a strong expertise in fish health and fish welfare. Specific terms of the agreement were not disclosed. The acquisition of Scan Aqua AS will include its Rx product portfolio with the key products AQUI-S® and Finquel. AQUI-S is a sedative for use during treatment, pumping, transportation, and handling of salmon and rainbow trout. Finquel is a widely-used anesthetic mainly used in fish farming during the vaccination process and any handling events that require the fish to be fully anesthetized, such as lice counting.
“The Scan Aqua AS acquisition reinforces MSD Animal Health’s commitment to investing in fish health and fish welfare, as well as to offering its customers new solutions. Vaccination is a key pillar of our preventative health solutions and the use of sedatives complements this approach,” says Dafydd Morris, General Manager MSD Animal Health Norway.
“We are delighted to work with MSD Animal Health. They are the ideal partner to help realize the full potential of our fish health products in Norway and in other markets,” says Ole Kristian Kaurstad, CEO, Scanvacc AS.
About MSD Animal Health
For more than a century, MSD, a leading global biopharmaceutical company, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases. MSD Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., USA, is the global animal health business unit of MSD. Through its commitment to the Science of Healthier Animals®, MSD Animal Health offers veterinarians, farmers, pet owners and governments one of the widest range of veterinary pharmaceuticals, vaccines and health management solutions and services. MSD Animal Health is dedicated to preserving and improving the health, well-being and performance of animals. It invests extensively in dynamic and comprehensive R&D resources and a modern, global supply chain. MSD Animal Health is present in more than 50 countries, while its products are available in some 150 markets.
About Scanvacc AS
Privately-held, Scanvacc AS develops, registers, markets, and sells pharmaceuticals for the aquaculture industry in Europe. The company was founded on August 12, 1997, and is headquartered at Hvam, Norway